Lifestyle
- Stress management techniques
- Regular moderate exercise
- Adequate sleep
Neutrophils · PMN · Neutrophile Granulozyten
Neutrophil count measures the number of neutrophils in the blood, reflecting the body's ability to respond to infections and inflammation.
Reference ranges may vary slightly based on age and laboratory standards.
Neutrophils, also known as neutrophile granulocytes, are a type of white blood cell that plays a crucial role in the immune response by defending the body against infections. They are the most abundant type of granulocytes and form an essential part of the innate immune system. Neutrophils are produced in the bone marrow and released into the bloodstream, where they circulate and respond to signals of infection or inflammation. Clinically, neutrophils are significant as their levels can reflect various health conditions. Elevated neutrophil counts, or neutrophilia, can indicate acute bacterial infections, inflammation, stress, or malignancies such as cancer. Conversely, low neutrophil counts, or neutropenia, may suggest bone marrow disorders, severe infections, or the effects of certain medications. Neutrophils are also implicated in cancer progression, where they can either promote or inhibit tumor growth, depending on their phenotype and the tumor microenvironment. For athletes and biohackers, neutrophil levels can be indicative of immune status and recovery from physical stress. While not directly related to performance, maintaining optimal immune function is crucial for overall health and longevity. Neutrophil levels can be influenced by various factors, including stress, infections, and medications. Time of day and fasting status can also affect neutrophil counts, with levels typically higher in the morning and potentially altered by recent food intake. Therefore, it is important to consider these factors when interpreting test results.
Klinische Bedeutung
Elevated neutrophil levels may indicate acute bacterial infections, inflammation, or stress, while low levels can suggest bone marrow disorders or severe infections.
Progressively rising neutrophil levels may suggest ongoing infection or inflammation. Re-test in 4 weeks if outside the optimal range.
Falling neutrophil levels may indicate resolving infection or potential bone marrow suppression.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider for personalized advice, especially if considering supplements.
Neutrophil levels may be higher in the morning; consistent timing for tests is recommended.
Testing Frequency
Annually for routine health checks, more frequently if monitoring specific conditions.
Current research suggests that the predictive value of tumour-associated neutrophils (TANs) remains debated, particularly regarding their location within tumors and the optimal reference ranges for their assessment. Researchers have not yet established the precise phenotypes of neutrophils that correlate with treatment efficacy across different cancer types. Additionally, clinical questions remain unanswered regarding the mechanisms by which neutrophils influence immunotherapy responses and the potential for targeted interventions in neuroinflammatory diseases.
2,695
Total Citations
7
Human/RCT
4.5
Avg. Influence
2025
Latest
This study examined the role of neutrophils in cancer, highlighting that a high circulating neutrophil-to-lymphocyte ratio is a strong indicator of poor clinical outcomes. Researchers found that tumour-associated neutrophils (TANs) may have conflicting roles in cancer progression, depending on their location. The review suggests future research directions for manipulating TANs in cancer patients.
Researchers discussed the dual role of neutrophils in cancer, noting their involvement in promoting tumor progression and serving as potential biomarkers for disease status. The study emphasized the need for understanding neutrophil behavior in the tumor microenvironment.
This study introduced an enzyme immunoassay for measuring human granulocyte elastase levels in plasma. Researchers established a reference range and discussed the diagnostic significance of elastase levels in inflammatory diseases. The assay is suitable for routine clinical use.
This study identified interferon-stimulated Ly6Ehi neutrophils as a predictive biomarker for immunotherapy response in cancer patients. Researchers found that these neutrophils can sensitize tumors to anti-PD1 therapy, demonstrating high accuracy in predicting treatment outcomes. The findings were validated in both mouse models and human cohorts.
This study reviewed the roles of neutrophils in cancer growth and progression, emphasizing their dual nature in tumor behavior. Researchers found that neutrophils exhibit plasticity and can influence tumor microenvironments, suggesting a need to reassess their functions in cancer initiation and progression.
This study explored the mechanisms of primary membranous nephropathy (MN), identifying autoantibodies as significant biomarkers for diagnosis and disease monitoring. Researchers observed that levels of these autoantibodies correlate with disease severity and may help in tracking treatment responses. The review also discusses emerging antigens associated with MN.
This study summarized the roles of neutrophils and platelets in neuroinflammatory diseases, highlighting their contributions to thromboinflammation. Researchers observed that interactions between these cells can disrupt brain barriers and amplify neuroinflammation. The review emphasizes the potential for targeting these interactions in treating neurological disorders.
This review highlighted the role of neutrophil extracellular traps (NETs) in stroke, noting their dual function in trapping pathogens and exacerbating inflammation. Researchers summarized mechanisms of NET formation and their contributions to stroke pathology, suggesting that targeting NETs could be a novel therapeutic approach.
Researchers studied the role of polymorphonuclear leukocytes in adult respiratory distress syndrome (ARDS). They observed abnormal accumulation of labeled PMNs in the lungs of patients with ARDS, suggesting a link to leukoaggregation. The study highlights the importance of PMNs in ARDS pathology.
Researchers discussed the potential of neutrophils as biomarkers and therapeutic targets in radiation therapy for cancer. The study emphasized the complex interplay between neutrophils and the tumor microenvironment, suggesting that neutrophil evaluation could enhance treatment outcomes.
14
Total Trials
2,609
Total Enrolled
OncoHost Ltd.
600
2025
Quantification of Ly6E high (Ly6Ehi) neutrophils in blood using the NeutroFlow flow cytometry assay
Aristotle University Of Thessaloniki
45
2025
Neutrophil Gelatinase-Associated Lipocalin
Kayseri City Hospital
60
2025
Neutrophil gelatinase-associated lipocalin (NGAL)
Mahmoud Kamel Mohamed Abd elhaq
200
2022
Neutrophils to Lymphocytes and platelets ratio (N/LP) as predictor of mortality in septic- acute kidney injury patients
Muğla Sıtkı Koçman University
35
2022
Early inflammation markers for VAP
Universitas Sebelas Maret
72
2022
Neutrophil-lymphocyte ratio (NLR)
Loyola University
42
2021
Urinary neutrophil gelatinase-associated lipocalin (NGAL)
Seoul National University Hospital
60
2019
serum neutrophil-gelatinase-associated lipocalin (NGAL)
INA-RESPOND Secretariat
188
2017
White Blood Cells and Absolute Neutrophil Count Cut-off Levels for Distinguishing of Viral and Bacterial/Mixed Pathogens
The Cleveland Clinic
149
2015
Urine Neutrophil Gelatinase-associated Lipocalin (NGAL) [Time Frame: 24 Hours After Surgery] [Designated as Safety Issue: Yes]
University of Freiburg
244
2011
to assess the value of uNGAL measurement 4 to 6 hours after PCP as a possible early detector of CIN
University of Pennsylvania
704
2010
Composite of i) All-cause Mortality or ii) End-stage Renal Disease
University Hospital Dubrava
60
2008
Neutrophil activity before and after the open or laparoscopic surgery - Serum concentrations of sFas, sFasL and IL - 17.
Hospital de Base
150
2007
Evaluate the urinary excretion of NGAL as a marker of early development of acute kidney injury in patients undergoing cardiac surgery
Research publications about Neutrophile over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer